Rafferty Asset Management, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 243 filers reported holding TG THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,163,157
-4.7%
856,837
+183.2%
0.04%0.0%
Q2 2023$7,514,796
+3.4%
302,528
-37.4%
0.04%
-14.3%
Q1 2023$7,264,846
-18.3%
483,035
-35.7%
0.05%
-33.8%
Q4 2022$8,893,546
+94.3%
751,779
-2.8%
0.07%
+51.0%
Q3 2022$4,577,000
+76.2%
773,210
+26.5%
0.05%
+104.2%
Q2 2022$2,598,000
-55.0%
611,405
+0.6%
0.02%
-29.4%
Q1 2022$5,779,000
-4.4%
607,625
+90.9%
0.03%
+6.2%
Q4 2021$6,046,000
+73.7%
318,234
+204.3%
0.03%
+33.3%
Q3 2021$3,481,000
+29.9%
104,596
+51.5%
0.02%
+41.2%
Q2 2021$2,679,000
-16.9%
69,059
+3.3%
0.02%
-22.7%
Q1 2021$3,223,000
+181.0%
66,864
+203.2%
0.02%
+100.0%
Q4 2020$1,147,000
-46.2%
22,053
-72.3%
0.01%
-57.7%
Q3 2020$2,132,000
+97.0%
79,653
+43.4%
0.03%
+73.3%
Q2 2020$1,082,000
+920.8%
55,557
+417.9%
0.02%
+275.0%
Q1 2020$106,000
-89.5%
10,727
-88.2%
0.00%
-75.0%
Q4 2019$1,011,000
-22.8%
91,063
-61.0%
0.02%
-20.0%
Q3 2019$1,310,000
-51.6%
233,340
-25.4%
0.02%
-58.3%
Q2 2019$2,705,000
+121.5%
312,773
+105.9%
0.05%
+140.0%
Q1 2019$1,221,000151,8860.02%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders